Tapping into These ‘Noble’ Stocks

Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker, financial journalist, and money manager.
dividend

As inflation continues to march on without an end in sight, investors are turning to dividend-paying stocks to provide some refuge from its effects.

While the status of dividend-paying stocks is always precarious — indeed, many dividends were reduced or eliminated after the recent economic downturn — there is a group of dividend-paying stocks whose members have a reputation for stability and consistency in their dividend payouts. Enter the Dividend Aristocrats. 

To earn this coveted label, a stock in the S&P 500 must have increased its dividend annually for at least the past 25 consecutive years. There are 65 stocks currently on this list as of 2021, ranging from the unglamourous Federal Realty Investment Trust (NYSE: FRT) to the well-known Coca-Cola Co. (NYSE:KO). In addition, an exchange-traded fund known as the ProShares S&P 500 Dividend Aristocrats ETF (BATS: NOBL) may show a way to tap into these stocks without having to own each one individually.

Like its parent list, the stocks in this exchange-traded fund’s (ETF) portfolio are selected from a list of companies on the S&P 500 that have increased their dividends for at least the past 25 consecutive years. All holdings are weighted equally, and each sector is limited to no more than 30% of the portfolio. At the same time, this methodology results in traditional dividend-paying sectors being overweighted in the portfolio.

Currently, the fund’s top holdings include Nucor Corporation (NYSE:NUE), Target Corporation (NYSE:TGT), Exxon Mobil Corporation (NYSE:XOM), Expeditors International of Washington, Inc. (NASDAQ:EXPD), West Pharmaceutical Services, Inc. (NYSE:WST), Franklin Resources, Inc. (NYSE:BEN), T. Rowe Price Group (NASDAQ: TROW) and the Cincinnati Financial Corporation (NASDAQ:CINF)

This fund’s performance has been relatively strong, even when including the damage done by the COVID-19 pandemic. As of June 29, NOBL has been down 1.55% over the past month and up 4.57% for the past three months. It is currently up 14.19% year to date.

Chart courtesy of www.stockcharts.com

The fund has amassed $8.6 billion in assets under management and has an expense ratio of 0.35%, making it less expensive to hold than many other ETFs.

While NOBL does provide an investor with a way to profit from the Dividend Aristocrats, this kind of ETF may not be appropriate for all portfolios. Thus, interested investors always should conduct their due diligence and decide whether the fund is suitable for their investing goals.

Like This Article?
Now Get Jim's FREE Special Report:
The Top 11 Dividend ETFs to
Buy Right Now

Get up to 5X the yields of traditional income plays.

Get Access to the Report, 100% FREE


img
previous article

Five biopharmaceutical stocks to buy offer investors a chance to profit while supporting companies that develop treatments for health problems through biological solutions. The five biopharmaceutical stocks to buy are part of an industry that generally is well-financed, with companies backed by an average of 3.5 years of cash to fund research and development (R&D) initiatives, com

PREMIUM SERVICES FOR INVESTORS

Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details

  • Forecasts & Strategies
  • Home Run Trader
  • Fast Money Alert
  • Five Star Trader
  • TNT Trader
LEARN MORE HERE

Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details

  • Cash Machine
  • Premium Income (exclusively for subscribers of Cash Machine)
  • Quick Income Trader
  • Breakout Profits Alert
  • Hi-Tech Trader
LEARN MORE HERE

Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details

  • Successful Investing
  • Intelligence Report
  • Bullseye Stock Trader
LEARN MORE HERE

Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details

  • Retirement Watch
  • Retirement Watch Spotlight Series
  • Lifetime Retirement Protection Program
LEARN MORE HERE

Jon Johnson

Jon Johnson's philosophy in investing and trading is to take what the market gives you regardless if that is to the upside or downside. For the past 21 years, Jon has helped thousands of clients gain success in the financial markets through his newsletters and education services:

Product Details

  • Investment House Daily
  • Technical Traders Alert
  • Success Trading Group
LEARN MORE HERE

DividendInvestor.com

Used by financial advisors and individual investors all over the world, DividendInvestor.com is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.

  • Dividend Investor
LEARN MORE HERE